Exane Derivatives Constellium Se Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Constellium Se stock. As of the latest transaction made, Exane Derivatives holds 28 shares of CSTM stock, worth $308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 3,359
99.17%
Holding current value
$308
Previous $60,000
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CSTM
# of Institutions
240Shares Held
123MCall Options Held
648KPut Options Held
583K-
T. Rowe Price Investment Management, Inc. Baltimore, MD15.6MShares$172 Million0.15% of portfolio
-
Bpifrance Sa Maisons Alfort, Cedex, I012.6MShares$139 Million7.02% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$126 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X06.15MShares$67.7 Million0.05% of portfolio
-
Westwood Holdings Group Inc Dallas, TX5.48MShares$60.3 Million0.71% of portfolio
About CONSTELLIUM SE
- Ticker CSTM
- Exchange NYSE
- Sector Basic Materials
- Industry Aluminum
- Shares Outstandng 144,302,000
- Market Cap $1.59B
- Description
- Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the packaging, aerospace, and automotive end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structure...